455 related articles for article (PubMed ID: 33931980)
21. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer.
Hu X; Bao J; Wang Z; Zhang Z; Gu P; Tao F; Cui D; Jiang W
Tumour Biol; 2016 Mar; 37(3):3497-504. PubMed ID: 26453113
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
[TBL] [Abstract][Full Text] [Related]
23. [Circulating long noncoding RNAs as biomarkers in tumor diagnosis].
Jiang N; Tian H; Pan J; Gong Z
Sheng Wu Gong Cheng Xue Bao; 2017 Jun; 33(6):910-922. PubMed ID: 28895353
[TBL] [Abstract][Full Text] [Related]
24. Overdiagnosis in low-dose computed tomography screening for lung cancer.
Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
[TBL] [Abstract][Full Text] [Related]
25. Sputum long non-coding RNA biomarkers for diagnosis of lung cancer.
Gupta C; Su J; Zhan M; Stass SA; Jiang F
Cancer Biomark; 2019; 26(2):219-227. PubMed ID: 31450489
[TBL] [Abstract][Full Text] [Related]
26. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
Pinsky P; Gierada DS
Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
[TBL] [Abstract][Full Text] [Related]
27. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
28. [Present Situation of Lung Cancer Screening Methods].
Zhang H; Zhang S
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):715-720. PubMed ID: 27760605
[TBL] [Abstract][Full Text] [Related]
29. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.
Li X; Liu L; Song X; Wang K; Niu L; Xie L; Song X
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1609-1622. PubMed ID: 33792796
[TBL] [Abstract][Full Text] [Related]
30. Radiation Risks in Lung Cancer Screening Programs.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-624. PubMed ID: 27845636
[TBL] [Abstract][Full Text] [Related]
31. Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer.
Jiang N; Meng X; Mi H; Chi Y; Li S; Jin Z; Tian H; He J; Shen W; Tian H; Pan J; Fang S; Jin X; Zhou C; Gong Z
Clin Chim Acta; 2018 Nov; 486():26-33. PubMed ID: 30025752
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
33. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
[TBL] [Abstract][Full Text] [Related]
34. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
35. A meta-analysis: is low-dose computed tomography a superior method for risky lung cancers screening population?
Fu C; Liu Z; Zhu F; Li S; Jiang L
Clin Respir J; 2016 May; 10(3):333-41. PubMed ID: 25307063
[TBL] [Abstract][Full Text] [Related]
36. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA in lung cancer.
Chen Z; Lei T; Chen X; Gu J; Huang J; Lu B; Wang Z
Clin Chim Acta; 2020 May; 504():190-200. PubMed ID: 31790697
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
Raghu VK; Zhao W; Pu J; Leader JK; Wang R; Herman J; Yuan JM; Benos PV; Wilson DO
Thorax; 2019 Jul; 74(7):643-649. PubMed ID: 30862725
[TBL] [Abstract][Full Text] [Related]
39. Serum and blood based biomarkers for lung cancer screening: a systematic review.
Chu GCW; Lazare K; Sullivan F
BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
[TBL] [Abstract][Full Text] [Related]
40. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]